Compare

ACE-031 vs SS-31

Side-by-side observational reports from PeptIQ users. This compares self-reported patterns — not clinical head-to-head trials.

Observational reporting only — not medical advice. Does not recommend doses, protocols, or treatments.

ACE-031

308 community reports

Overall experience

From check-in ratings — separate from side effects logged below. Side effects are logged separately from overall experience. A favorable check-in can still include nausea, fatigue, or injection-site reactions.

Favorable 62% · Mixed 22% · Unfavorable overall 16%

Most reported benefits

Benefits users selected when logging a favorable or mixed check-in.

Joint comfort
-149
Recovery
-31
Digestive comfort
-151
Skin appearance
-99
Appetite control
-47

Most logged side effects

Side effects are logged separately from overall experience. A favorable check-in can still include nausea, fatigue, or injection-site reactions.

Injection site reaction
-53
Anxiety
-132
Flushing
-6
Headache
-103
GI discomfort
-48

Self-reported dose per injection

Median bucket: 200–400 mcg · Most common: 100–200 mcg

Reports span 25–1000 mcg

25–50
4
50–100
14
100–200
18
200–400
9
400–600
6
600–1000
1

Anonymized self-reports from PeptIQ users — not prescribing guidance. Buckets group similar logged amounts; open-ended top buckets mean “at least” that dose.

Common discussion topics

timing32stacking10side effects28ace-03116

How repeat users are trending

Among repeat reporters, 57% said they felt similar to their last entry, 30% more positive, and 12% more negative.

Overall, repeat reporters leaned more positive than their previous entry.

Median gap between entries: 28 days · Based on 68 repeat reporters

SS-31

58 community reports

Overall experience

From check-in ratings — separate from side effects logged below. Side effects are logged separately from overall experience. A favorable check-in can still include nausea, fatigue, or injection-site reactions.

Favorable 2% · Mixed 2% · Unfavorable overall 96%

Most reported benefits

Benefits users selected when logging a favorable or mixed check-in.

Energy
187

Most logged side effects

Side effects are logged separately from overall experience. A favorable check-in can still include nausea, fatigue, or injection-site reactions.

Injection site irritation
183

Self-reported dose per injection

Median bucket: 5+ mg · Most common: 5+ mg

Reports span 0.025 to ≥ 5 mg (open-ended top bucket)

0.025–0.05 mg
10
0.2–0.4 mg
2
0.4–0.6 mg
1
0.6–1 mg
4
1–2 mg
18
2–3 mg
20
3–5 mg
6
5+ mg
125

Anonymized self-reports from PeptIQ users — not prescribing guidance. Buckets group similar logged amounts; open-ended top buckets mean “at least” that dose.

How repeat users are trending

Among repeat reporters, 92% said they felt similar to their last entry, 8% more positive, and 0% more negative.

Overall, repeat reporters leaned more positive than their previous entry.

Median gap between entries: 73 days · Based on 37 repeat reporters